🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Combination therapy in pulmonary arterial hypertension (PAH) has been the s...
Status
Completed
Location
Providence Medical Foundation
Start Date
2019-07-29
Trial ID
NCT03904693
The purpose of this study is to demonstrate bioequivalence on the primary p...
Status
Completed
Location
Celerion
Start Date
2020-01-17
Trial ID
NCT04235270
Treatments Being Tested
The main purpose of this study is to evaluate the safety and tolerability a...
Status
Completed
Location
Sumida Hospital
Start Date
2020-07-21
Trial ID
NCT04500808
Treatments Being Tested
The study is intended to demonstrate that macitentan does not have an effec...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT02050802
Treatments Being Tested
Single dose oral bioequivalence study of Macitentan and Tadalafil film-coat...
Status
Completed
Location
Cliantha Research Limited
Start Date
2024-05-10
Trial ID
NCT06553937
Treatments Being Tested
The purpose of this study is to evaluate the effect of macitentan on hemody...
Status
Completed
Location
Nagano Children's Hospital
Start Date
2022-11-14
Trial ID
NCT05167825
Treatments Being Tested
The purpose of this study is to assess the rate and extent of absorption of...
Status
Completed
Location
SGS Belgium NV
Start Date
2022-05-25
Trial ID
NCT05392530
Treatments Being Tested
Chronic thromboembolic pulmonary hypertension (CTEPH) is characterised by a...
Status
Completed
Location
Hôpital Bicêtre
Start Date
2021-06-14
Trial ID
NCT04780932
Treatments Being Tested
The purpose of the study is to evaluate the effect of macitentan 75 mg vers...
Status
Terminated
Location
University of California San Diego Medical Center
Start Date
2020-07-07
Trial ID
NCT04271475
Treatments Being Tested
The purpose of this study is to demonstrate bioequivalence on the primary p...
Status
Completed
Location
PRAHS
Start Date
2022-02-04
Trial ID
NCT05236231
Treatments Being Tested